Home » Newsletters » BioWorld Science

BioWorld Science

May 17, 2002

View Archived Issues

Paxil approved in Canada for posttraumatic stress disorder

Zycos and Pharmexa sign cancer vaccine formulation agreement

Tachykinin NK1 antagonists identified at Merck

New factor Xa inhibitors patented by Sankyo

Novel antifungal agents in the BMS pipeline

Agents with dual AChE-inhibitory/antioxidant activity for use in AD

Bayer describes IkappaB kinase inhibitors as potential antiasthmatic agents

Chemokine receptor modulators claimed by AnorMED

Update on status of T-614, a new antiarthritic drug

JT to advance three products to phase III by March 2004

Novel adenoviral vector efficiently delivers E1A to tumor cells and reduces tumorigenic capacity

Locally administered AS ODN targeting a common cytokine receptor subunit for asthma

Diabetic fruit flies may provide new information on the development of human pancreatic beta-cells

Synergistic effects of the CCR5 antagonist SCH-C combined with other antiretroviral drugs

Crosslinking of thymosin beta4 to fibrin may underlie wound healing

Rho kinase as a potential target for erectile dysfunction Rx

Corixa to request appeal to FDA stance on Bexxar

Novel treatments for male erectile dysfunction

BioMarin initiates preclinical studies of NeuroTrans brain delivery technology

Mimotopes and Baker Medical Research Institute to develop novel cardiovascular drugs

RSV antibody production in greenhouse plant lines

Antistaphylococcal monoclonal antibody provides encouraging phase I results

BTG acquires HIV treatment technology from BioClonetics

ATL-104 safe and well tolerated in phase Ib trial

CeNeS updates progress of key pain products

T-20 provides positive 24-week results in second phase III HIV study

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...